Xiaoyan Wu

510 total citations
21 papers, 366 citations indexed

About

Xiaoyan Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiaoyan Wu has authored 21 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Xiaoyan Wu's work include Cancer-related molecular mechanisms research (4 papers), Inflammasome and immune disorders (3 papers) and Circular RNAs in diseases (3 papers). Xiaoyan Wu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Inflammasome and immune disorders (3 papers) and Circular RNAs in diseases (3 papers). Xiaoyan Wu collaborates with scholars based in China, Hong Kong and United States. Xiaoyan Wu's co-authors include Ziwei Xu, Pingzheng Zhou, Ying Cao, Linjie Zhang, Runming Jin, Zhenhua Luo, Weihong Liang, Jianwen Zhou, Peng Zhou and Xu‐Lin Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoyan Wu

21 papers receiving 365 citations

Peers

Xiaoyan Wu

IMMUN

PHYSI

PRM

Xinglan He China

Ilias Gkikas Greece

Amruta Singh India

Pascal Yazbeck United States

Geer Tian China

Zhonggai Chen China

Yihao Wang China

Faiza Waheed Canada

Zhangbin Gong China

Janset Onyuru United States

Xinglan He China

Xiaoyan Wu

231 ×0.8

55 ×0.6

63 ×1.0

IMMUN

21 ×0.8

PHYSI

23 ×1.0

PRM

Citations per year, relative to Xiaoyan Wu Xiaoyan Wu (= 1×) peers Xinglan He

Countries citing papers authored by Xiaoyan Wu

Since Specialization

Citations

This map shows the geographic impact of Xiaoyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Wu more than expected).

Fields of papers citing papers by Xiaoyan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Wu. The network helps show where Xiaoyan Wu may publish in the future.

Co-authorship network of co-authors of Xiaoyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Wu. A scholar is included among the top collaborators of Xiaoyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Wu. Xiaoyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xiaoyan, et al.. (2025). A Lrp/ AsnC Family Transcriptional Regulator Lrp Is Essential for the Pathogenicity of Dickeya oryzae. Molecular Plant Pathology. 26(6). e70100–e70100. 1 indexed citations

Zong, Zhaojing, et al.. (2024). Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Frontiers in Pharmacology. 15. 1406454–1406454. 4 indexed citations

Wu, Xiaoyan, Yanshan Chen, Xingyuan Chen, et al.. (2023). A novel TWIK2 channel inhibitor binds at the bottom of the selectivity filter and protects against LPS-induced experimental endotoxemia in vivo. Biochemical Pharmacology. 218. 115894–115894. 2 indexed citations

Chen, Lei, et al.. (2022). Qishen Yiqi dropping pills improve cardiomyocyte hypertrophy via the lncRNA TINCR/miR-193b-3p/RORA axis. Journal of Thoracic Disease. 14(11). 4372–4383. 5 indexed citations

Wu, Xiaoyan, Shiqing Zhang, Xin Yi, et al.. (2021). ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome. Acta Pharmacologica Sinica. 43(4). 992–1000. 19 indexed citations

Gao, Yuan, et al.. (2021). Circular RNA FOXP1 relieves trophoblastic cell dysfunction in recurrent pregnancy loss via the miR-143-3p/S100A11 cascade. Bioengineered. 12(1). 9081–9093. 18 indexed citations

Xu, Huan, Hui Yu, Runming Jin, Xiaoyan Wu, & Hongbo Chen. (2021). Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia. Cells. 10(12). 3349–3349. 13 indexed citations

Xu, Ziwei, et al.. (2020). Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation. Frontiers in Immunology. 11. 609441–609441. 83 indexed citations

Xu, Ziwei, et al.. (2020). Inhibition of hyperpolarization-activated cyclic nucleotide-gated channels with natural flavonoid quercetin. Biochemical and Biophysical Research Communications. 533(4). 952–957. 3 indexed citations

10.

Luo, Bin, Chuang Chen, Xiaoyan Wu, et al.. (2020). Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients. Frontiers in Oncology. 10. 1379–1379. 9 indexed citations

11.

Wu, Xiaoyan, et al.. (2020). MiR-628–5p Inhibits Cervical Carcinoma Proliferation and Promotes Apoptosis by Targeting VEGF. The American Journal of the Medical Sciences. 361(4). 499–508. 11 indexed citations

12.

Wang, Jianhe, et al.. (2019). Bacterial quorum‐sensing signal IQS induces host cell apoptosis by targeting POT1–p53 signalling pathway. Cellular Microbiology. 21(10). e13076–e13076. 16 indexed citations

13.

Zhang, Shiqing, Ziwei Xu, Xiaoyan Wu, et al.. (2019). DCPIB, an Inhibitor of Volume-Regulated Anion Channels, Distinctly Modulates K2P Channels. ACS Chemical Neuroscience. 10(6). 2786–2793. 31 indexed citations

14.

Wang, Jun, et al.. (2018). WITHDRAWN: Exploring functions of long non-coding RNAs in HIV-associated neurocognitive disorder through weighted gene co-expression network analysis. Oncotarget. 0(0). 1 indexed citations

15.

Xie, Dan, Lulu Wang, Qi Xiao, et al.. (2018). New Insight into the Octamer of TYMS Stabilized by Intermolecular Cys43-Disulfide. International Journal of Molecular Sciences. 19(5). 1393–1393. 5 indexed citations

16.

Shen, Qi, Jun Li, Junhua Mai, et al.. (2018). Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis. Cell Death and Disease. 9(10). 19 indexed citations

17.

Wu, Xiaoyan, et al.. (2017). Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia. International Journal of Nanomedicine. Volume 12. 8025–8034. 11 indexed citations

18.

Zhang, Jing, Vivi Kasim, Yudan Xie, et al.. (2017). Inhibition of PHD3 by salidroside promotes neovascularization through cell–cell communications mediated by muscle-secreted angiogenic factors. Scientific Reports. 7(1). 43935–43935. 32 indexed citations

19.

Zhou, Fen, Yunyun Xu, Yining Qiu, et al.. (2014). Ik6 expression provides a new strategy for the therapy of acute lymphoblastic leukemia. Oncology Reports. 31(3). 1373–1379. 7 indexed citations

20.

Zhou, Peng, Weiyi Xu, Zhenhua Luo, et al.. (2013). Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 3′UTR of a Gene Is Targeted by Multiple miRNAs. PLoS ONE. 8(7). e68204–e68204. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact